You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
一圖看懂康哲藥業(00867.HK)2020年全年業績
格隆匯 03-16 22:22

康哲藥業(00867.HK)是一家全球創新驅動,聚焦中國市場的專業醫藥企業。集團專注於佈局全球首創,或擁有創新制劑、創新給藥方式等以達到同類治療效果最佳、最安全、或最具效益比的創新藥物;已建立創新等級較高、市場潛力大、有競爭差異性優勢的創新管線。集團擁有二十餘年已被驗證的成功藥品推廣經驗,在售眾多藥品擁有領先的市場地位。集團在強產品力、強銷售推廣能力和專業、高效、精細化的內部管理體系共同驅動下成為中國醫藥行業管理效率最高的公司之一。集團藉助自身優勢,在多個專業領域縱深發展的同時不斷擴張業務邊界,快速推進康哲大健康及康哲皮膚醫美等新業務板塊的發展。2020年,在產品力、銷售推廣力、精細化管理體系的聯合發力下,康哲藥業全年業績實現良好增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account